BE900749A - MICROENCAPSULE DRUG IN A SWEET MATRIX. - Google Patents

MICROENCAPSULE DRUG IN A SWEET MATRIX.

Info

Publication number
BE900749A
BE900749A BE0/213776A BE213776A BE900749A BE 900749 A BE900749 A BE 900749A BE 0/213776 A BE0/213776 A BE 0/213776A BE 213776 A BE213776 A BE 213776A BE 900749 A BE900749 A BE 900749A
Authority
BE
Belgium
Prior art keywords
medicament
microencapsule
drug
sweet
matrix
Prior art date
Application number
BE0/213776A
Other languages
French (fr)
Original Assignee
Rotman Avner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotman Avner filed Critical Rotman Avner
Publication of BE900749A publication Critical patent/BE900749A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/42—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G1/426—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un médicament administrable par voie orale est préparé sous une forme galénique qui élimine le gout et la sensation désagréables dans la bouche du médicament et est facilement et agréablement ingéré, meme par des enfants, par microencapsulation du médicament et enrobage des microcapsules dans une matrice tendre, sucrée, agréable au gout, comme du chocolat. Le principe actif est un agent anti-bactérien, un analgésique, un agent anti-histaminique, anti-inflammatoire, anti-hypertenseur, hypnotique, calmant, tranquilisant ou autre.A medicament for oral administration is prepared in a galenical form which eliminates the unpleasant taste and sensation in the mouth of the medicament and is easily and pleasantly ingested, even by children, by microencapsulation of the medicament and coating of the microcapsules in a tender matrix, sweet, pleasant to the taste, like chocolate. The active ingredient is an anti-bacterial agent, an analgesic, an anti-histamine, anti-inflammatory, anti-hypertensive, hypnotic, calming, tranquilizing or other agent.

BE0/213776A 1983-10-03 1984-10-03 MICROENCAPSULE DRUG IN A SWEET MATRIX. BE900749A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US53880183A 1983-10-03 1983-10-03

Publications (1)

Publication Number Publication Date
BE900749A true BE900749A (en) 1985-02-01

Family

ID=24148464

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/213776A BE900749A (en) 1983-10-03 1984-10-03 MICROENCAPSULE DRUG IN A SWEET MATRIX.

Country Status (14)

Country Link
JP (1) JPS60105612A (en)
AU (1) AU3379984A (en)
BE (1) BE900749A (en)
CA (1) CA1239585A (en)
CH (1) CH661663A5 (en)
DE (1) DE3435747A1 (en)
DK (1) DK472584A (en)
FR (1) FR2552665B1 (en)
GB (1) GB2147501B (en)
IL (1) IL73157A (en)
IT (1) IT1178019B (en)
NL (1) NL8403003A (en)
SE (1) SE8404808L (en)
ZA (1) ZA847743B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749575A (en) * 1983-10-03 1988-06-07 Bio-Dar Ltd. Microencapsulated medicament in sweet matrix

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937076A (en) * 1984-08-10 1990-06-26 Combe Incorporated Chewable aspirin and buffering material tablet and method for producing same
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
SE8605515D0 (en) * 1986-12-22 1986-12-22 Astra Laekemedel Ab A LIQUID DOSAGE FORM FOR ORAL ADMINISTRATION OF A PHARMACEUTICALLY ACTIVE SUBSTANCE
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
GR1001437B (en) * 1992-11-05 1993-12-30 Aggelos Kontos Pastry system for the administration of pharmacologically active substances.
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
AU5135898A (en) * 1996-12-03 1998-06-29 Schering-Plough Kabushiki Kaisha Controlled release matrix tablet and method for its preparation
US6328994B1 (en) * 1998-05-18 2001-12-11 Takeda Chemical Industries, Ltd. Orally disintegrable tablets
EP1561458B1 (en) 1998-07-28 2010-09-15 Takeda Pharmaceutical Company Limited Rapidly disintegrable solid preparation
GB2356346A (en) * 1999-11-19 2001-05-23 Mars Uk Ltd Food product for oral delivery of a pharmaceutical agent to a non-human animal comprising encapsulated particles of said agent distributed within the product
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
SE0103210D0 (en) * 2001-09-27 2001-09-27 Pharmacia Ab New formulations and use thereof
US7371405B2 (en) 2003-12-22 2008-05-13 Mcneil-Ppc, Inc. Consumer customized dosage forms
CA2790097A1 (en) * 2010-03-05 2011-09-09 Ophthalmopharma Ag Nutraceutical chocolate or compound chocolate product
CA2977168C (en) 2015-03-31 2020-01-28 Laboratorios Bago S.A. Enteric-coated pellets containing a proton pump inhibitor

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB490001A (en) * 1936-12-03 1938-08-02 Atlantic Coast Fisheries Co Improvements in or relating to a vitamin product
GB543309A (en) * 1940-12-04 1942-02-19 John David Evans Improvements in or relating to drugs
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
US3697641A (en) * 1970-01-02 1972-10-10 Gerhard W Ahrens Nonhygroscopic non-sugarbase noncariogenic-vitamin c releasable base material for use in the preparation of suckable tablets,lozenges and chocolate
CH519858A (en) * 1971-05-04 1972-03-15 Interfood S A Heat-resistant sweets - contg encapsulated fats and cocoa materials
GB1403584A (en) * 1972-05-19 1975-08-28 Beecham Group Ltd Control medicaments
BE791458A (en) * 1972-07-31 1973-05-16 Merck & Co Inc MICROENCAPSULE PRODUCT
DE2347713C3 (en) * 1972-09-25 1980-03-06 Warner-Lambert Co., Morris Plains, N.J. (V.St.A.) Acetylsalicylic acid chewable tablet
US4288460A (en) * 1979-05-24 1981-09-08 Balchem Corporation Non-caking, water-soluble, granular coated food ingredient
US4271142A (en) * 1979-06-18 1981-06-02 Life Savers, Inc. Portable liquid antacids
GB2075818B (en) * 1980-05-21 1984-09-05 Farm Feed Holdings Ltd Torrefied cereals for use in the feeding and veterinary treatment of ruminant animals
US4327077A (en) * 1981-05-29 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
EP0083372B1 (en) * 1981-07-15 1988-05-18 Key Pharmaceuticals, Inc. Sustained release theophyline

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749575A (en) * 1983-10-03 1988-06-07 Bio-Dar Ltd. Microencapsulated medicament in sweet matrix

Also Published As

Publication number Publication date
DK472584D0 (en) 1984-10-02
ZA847743B (en) 1985-06-26
FR2552665B1 (en) 1988-09-09
AU3379984A (en) 1985-04-18
CH661663A5 (en) 1987-08-14
IT8448945A1 (en) 1986-04-03
FR2552665A1 (en) 1985-04-05
DE3435747A1 (en) 1985-04-11
SE8404808D0 (en) 1984-09-26
GB8424833D0 (en) 1984-11-07
NL8403003A (en) 1985-05-01
GB2147501B (en) 1988-01-27
JPS60105612A (en) 1985-06-11
DK472584A (en) 1985-04-04
SE8404808L (en) 1985-04-04
CA1239585A (en) 1988-07-26
IL73157A0 (en) 1985-01-31
IT1178019B (en) 1987-09-03
IT8448945A0 (en) 1984-10-03
GB2147501A (en) 1985-05-15
IL73157A (en) 1988-10-31

Similar Documents

Publication Publication Date Title
BE900749A (en) MICROENCAPSULE DRUG IN A SWEET MATRIX.
US6406717B2 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
DE60127379D1 (en) FUNCTIONAL COATING OF LINEZOLID MICROPHONES FOR TASTE MASKING AND ASSOCIATED ORAL DRUG PREPARATION
HUP0104039A2 (en) Multiparticulate modified release composition
HUP0003583A2 (en) Therapeutic agents containing ibuprofen
DZ1078A1 (en) Pharmaceutical formulation of acid labile substance for oral administration.
DE69532031D1 (en) MEDIA CONTAINING THYROID HORMONES
EP1161956A4 (en) Medicinal compositions
ATE252892T1 (en) MEDICINAL PRODUCTS COMPOSED OF SEVERAL UNITS WITH NON-STEROIDAL ACTIVE INGREDIENTS (NSAIDS)
IT1211484B (en) PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION WITH CONTROLLED DISPENSING OF AN ACTIVE INGREDIENT
US4876283A (en) Antisnoring agent
EP0350701A3 (en) Pharmaceutical cmpositions for oral administration having analgesic and anti-inflammatory activity, possessing excellent palatability and being free of irritating effects on mucous membranes
FR2712807B1 (en) Solid mucoadhesive, therapeutic or hygienic composition, for administration by application to the oral or nasal mucosa.
US5702723A (en) Multi-stage delivery system for ingestible medications or nutrients
WO2002092067A1 (en) Compositions for transmucosal administration containing coenzyme q as the active ingredient
EP0390832A1 (en) Medicinal preparation comprising the association of colistin, tobramycin and amphotericin b administered by atomization
EP0271151A3 (en) Azumolene dosage form
EP0402208B1 (en) Mixture of Vitamin A in physiological dosis and different active ingredients having therapeutic effect
WO2002056867A3 (en) Extended release pharmaceutical compositions containing beta-lactam antibiotics
KR890003386A (en) Antihyperlipidemic agents
US20060062811A1 (en) Medicinal cooling emulsions
AP9901724A0 (en) Process for the preparation of astable fixed dose pharmaceutical composition of anti-infective agent/ agents and microorganisms as active ingredients.
KR0129409B1 (en) Process for preparing chewable soft tablet
FR2750859B1 (en) PHARMACEUTICAL COMPOSITION INTENDED FOR ORAL ADMINISTRATION WITH ABSORPTION OF AT LEAST ONE ACTIVE INGREDIENT THROUGH THE MUCOSA OF THE MOUTH
DK200000687A (en) Agent for attempting the delivery of cerebral acetylcholine

Legal Events

Date Code Title Description
CH Change of patent owner

Owner name: *BIO-DAR LTD

Effective date: 19841003

RE Patent lapsed

Owner name: BIO-DAR LTD

Effective date: 20001031